Results of Two Large Phase III Trials (CLL8 and REACH) Show Rituxan plus Chemotherapy Delayed Disease Progression in First- and Second-line Chronic Lymphocytic Leukemia South San Francisco, Calif. and Cambridge, Mass., Dec 6, 2008 –(HSMN NewsFeed)– Ge…
Biopharmaceuticals, Oncology
Genentech, Biogen Idec, Rituxan, rituximab, chronic lymphocytic leukemia
Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.
To get the details: Click Here
